Schizophrenia is a chronic mental sickness that impacts how an individual thinks and behaves. Notably, environmental dynamics like stressful events and natural disasters have been realized to enhance the risk of getting the disease (Altamura, Fagiolini, Galderisi, Rocca & Rossi, 2014). Therefore, this paper discusses the biological and behavioral components of schizophrenia and how stigmas can impact the diagnosis of mental illness.
Genetics plays an important role in the development of schizophrenia among certain individuals. In essence, when both the parents have the syndrome, the chances that they will produce a kid with the ailment is 40% an indication that the disorder is biologically passed (Patel, Cherian, Gohil & Atkinson, 2014). However, methods that can be applied to manage the disorder include the use of supportive counseling and individual therapy.
Behavioral components social isolation, reduced effective response, poor social drive, and minimized sense of purpose (Candida et al., 2016). Notably, treatment option entails the use of cognitive behavioral therapy that alters the dysfunctional thoughts to adapted and accurate choices thereby advancing their interactions.
Mental Health Stigmas
Mental health stigma exists in various components such as intrapersonal, interpersonal, and structural stigma (Knaak, Mantler & Szeto, 2017). As such, the issue impedes diagnosis and treatment of schizophrenic patients as it delays an individual from seeking assistance, halts treatment, impacts client’s safety concern, and affects suboptimal therapeutic relations.
Schizophrenia is a mental disease that has been linked to both biological and environmental causes and the disorder affects how a person thinks. Importantly, the condition can be managed through cognitive behavioral therapy which provides an alternative to personal thoughts and encourages interaction. Consequently, availability of mental stigmas impacts treatment of the sickness as it prevents the sick from seeking help and halts suboptimal therapeutic relations.
Altamura, C., Fagiolini, A., Galderisi, S., Rocca, P., & Rossi, A. (2014). Schizophrenia today: epidemiology, diagnosis, course and models of care. Journal of Psychopathology, 20, 223-243. Retrieved from: www.jpsychopathol.it/issues/2014/vol20-3/01_schizofrenia-inglese.pdf
Candida, M., Campos, C., Monteiro, B., Rocha, N. B. F., Paes, F., Nardi, A. E., & Machado, S. (2016). Cognitive-behavioral therapy for schizophrenia: an overview on efficacy, recent trends and neurobiological findings. MedicalExpress, 3(5). Retrieved from: www.scielo.br/scielo.php?pid=S2358-04292016000500001&script=sci_arttext
Knaak, S., Mantler, E., & Szeto, A. (2017, March). Mental illness-related stigma in healthcare: Barriers to access and care and evidence-based solutions. In Healthcare management forum (Vol. 30, No. 2, pp. 111-116). Sage CA: Los Angeles, CA: SAGE Publications. Retrieved from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5347358/
Patel, K. R., Cherian, J., Gohil, K., & Atkinson, D. (2014). Schizophrenia: overview and treatment options. Pharmacy and Therapeutics, 39(9), 638. Retrieved from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4159061/